Haemonetics Competitors and Similar CompaniesClear all
Haemonetics's competitors and similar companies include Glaukos.
 Glaukos Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. | ||
Founding Date | Founding Date 1971 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Aliso Viejo, US HQ Buenos Aires, AR Heatherton, AU Sao Paulo, BR Richmond Hill, CA San José, CR Wiesbaden, DE see more | |
Employees | Employees 3,65721% increase | Employees 90716% increase |
Valuation ($) | Valuation ($) 3.7 b | Valuation ($) 7.6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) $507.4m (FY, 2025) |
Cost of goods | Cost of goods $611.9m (FY, 2025) | Cost of goods $111.8m (FY, 2025) |
Gross profit | Gross profit $749m (FY, 2025) | Gross profit $282.8m (FY, 2025) |
Net income | Net income $167.7m (FY, 2025) | Net income ($187.7m) (FY, 2025) |
Operating ⚠ | ||
Facility Space Leased, sq. ft. | Facility Space Leased, sq. ft. 885.4 k (FY, 2023) | Facility Space Leased, sq. ft. 318 k (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Glaukos
HQ
Aliso Viejo, US
Employees
907↑ 16% increase
Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases.
View company